Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Colonic Neoplasms × cemiplimab × 90 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 19 Skin Neoplasms 7 Melanoma 7 Lung Neoplasms 6 Neoplasm Metastasis 4 Squamous Cell Carcinoma of Head and Neck 3 Carcinoma, Squamous Cell 3 Carcinoma, Renal Cell 3 Breast Neoplasms 3 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Recurrence 2 Neoplasms 2 Glioblastoma 2 Carcinoma, Merkel Cell 2 Carcinoma, Large Cell 2 Carcinoma, Basal Cell 2 Adenocarcinoma 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Solid Tumors 1 Sinonasal Squamous Cell Carcinoma 1 SMARCB1-Deficient Malignancies 1 Resectable Non-small Cell Lung Cancer 1 Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pathologic Complete Response 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1

Interventions

Cetuximab 13 Oxaliplatin 12 Fluorouracil 10 Leucovorin 9 Bevacizumab 9 pembrolizumab 7 Irinotecan 7 Nivolumab 6 Capecitabine 5 Folfox protocol 4 encorafenib 3 dostarlimab 3 Trastuzumab 3 Specimen Handling 3 Pemetrexed 3 Magnetic Resonance Spectroscopy 3 Immune Checkpoint Inhibitors 3 Gemcitabine 3 Exercise 3 Cisplatin 3 Carboplatin 3 trifluridine tipiracil drug combination 2 regorafenib 2 pertuzumab 2 fludarabine 2 dehydroftorafur 2 adagrasib 2 Watchful Waiting 2 Radiotherapy 2 Paclitaxel 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07224022 2026-02-04

NACho

Duke University

Phase 2 Not yet recruiting

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡